US Patent No: 5,965,167

Number of patents in Portfolio can not be more than 2000

Dosage units

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

The invention relates to a novel dosage unit for the sustained-release delivery of active agents as well as compositions and methods for making same.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
FUISZ TECHNOLOGIES LTD.CHANTILLY, VA90

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mezaache, Djelila 8609 Accoueek St., Laurel, MD 20724 4 30
Prior, David P 19925 Upland Terreace, Ashburn, VA 20147 2 10
Sanghvi, Pradeepkumar P Herndon, VA 13 173
Szedlock, Scott J 4447 Fair Stone Dr.,No. 102, Fairfax, VA 22033 2 29

Cited Art

Patent Info (Count) # Cites Year
 
ADVANCED TECHNOLOGY PHARMACEUTICALS CORP. (2)
5,292,534 Sustained release composition and method utilizing xanthan gum and an active ingredient 29 1992
5,427,799 Sustained release composition and method utilizing xanthan gum and an active ingredient 20 1993
 
HAUSER-KUHRTS, INC. (2)
5,023,245 Improved niacin formulation 29 1989
5,118,510 Niacin drink mix formulation 18 1989
 
FUISZ TECHNOLOGIES LTD. (1)
5,849,223 Liquiflash particles and method of making same 10 1995
 
HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (1)
5,037,658 Direct dry compressible acetaminophen composition 9 1989
 
TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 96 1990
 
VALEANT INTERNATIONAL BERMUDA (1)
5,683,720 Liquiflash particles and method of making same 37 1994
 
WASHINGTON UNIVERSITY (1)
5,047,427 Treatment for secondary diabetes effects 5 1988

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
COSMO TECHNOLOGIES LIMITED (3)
8,029,823 Controlled release and taste masking oral pharmaceutical composition 2 2008
8,293,273 Controlled release and taste masking oral pharmaceutical composition 0 2012
RE43799 Controlled release and taste masking oral pharmaceutical composition 0 2012
 
DEPOMED, INC. (3)
8,377,453 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2009
8,372,432 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2009
8,394,408 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2012
 
BIOVAIL TECHNOLOGIES (2)
7,815,937 Quick dissolve compositions and tablets based thereon 0 2002
7,709,023 Quick dissolve compositions and tablets based thereon 0 2002
 
THE FOUNDATION FOR INNOVATIVE THERAPIES, INC. (1)
7,012,086 Treatment of retrovirus induced derangements with niacin compounds 0 2000
 
WOCKHARDT EUROPE LIMITED (1)
6,555,139 Preparation of micron-size pharmaceutical particles by microfluidization 13 1999